 AUSTIN, TX ACCESSWIRE March 19, 2021 Apollo Endosurgery, Inc. Apollo NASDAQ:APEN, a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced the terms of equity awards granted to Chas McKhann in connection with his appointment as the companys CEO in March 2021. The companys board of directors granted Chas a stock option to purchase an aggregate of 848,733 shares of common stock, at a per share exercise price of 5.95, and a performance-based restricted stock unit award for 707,278 shares of common stock. 